Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy

NCT05990608 | Completed DMC

• 1 other identifier: 2021/371
• Study Type: observational
• Target: 48
• Locations: 1 country
• Sites: 1

Brief Summary

To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).

Conditions

Duchenne Muscular Dystrophy (DMD)

Keywords

Duchenne Muscular Dystrophy (DMD); Peabody Developmental Motor Scales-2

Outcome Measures

Primary Outcomes (1)

• Peabody Developmental Motor Scales-2

  This assessment will take place over the course of the study started and to the finish time

Study Arms (2)

Group I

Healthy Children

Other: Peabody Developmental Motor Scales-2, PDMS

Group II

Children with DMD

Other: Peabody Developmental Motor Scales-2, PDMS

Interventions

Peabody Developmental Motor Scales-2, PDMS OTHER

The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as "very low, low, below average, above average, high, very high".

Group I; Group II

Eligibility Criteria

• Age: 3 Years - 5 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)
• Sampling Method: Probability Sample

Study Population

Ondokuz Mayıs University, Health Application and Research Center, Pediatric Neurology Outpatient Clinic and community samples

You may qualify if:

• for Group I:
• No neurodevelopmental problems or diseases
• years old
• Being able to cooperate with the instructions given by the physiotherapist.
• Children who volunteered to participate in the study and whose families gave consent form will be included in the study.
• for Group II:
• Being diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist
• years old
• Children who volunteered to participate in the study and whose parents' consent was obtained will be included in the study.

You may not qualify if:

• Children with a behavioral condition and any disorder that interferes with testing (eg autism spectrum disorder)
• Failure to cooperate with the physiotherapist who made the evaluations.
• Lack of volunteers.

Sponsors & Collaborators

• Ondokuz Mayıs University: lead

Study Sites (1)

Ondokuz Mayıs University

Samsun, 55270, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular Dystrophies; Muscular Disorders, Atrophic; Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Genetic Diseases, X-Linked; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

• Deniz Çakır

  Ondokuz Mayıs University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: July 31, 2023
• First Posted: August 14, 2023
• Study Start: July 30, 2021
• Primary Completion: July 30, 2022
• Study Completion: July 30, 2023
• Last Updated: August 14, 2023

Record last verified: 2023-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)